<DOC>
	<DOCNO>NCT02508688</DOCNO>
	<brief_summary>The management refractory hepatic hydrothorax challenge usually unsuccessful . The study discuss perioperative treatment , effectiveness , morphology diaphragmatic defect hepatic hydrothorax thoracoscopic mesh repair . Risk factor associate increased three-month mortality critically ill patient study .</brief_summary>
	<brief_title>Thoracoscopic Mesh Repair Diaphragmatic Defects Hepatic Hydrothorax</brief_title>
	<detailed_description>Objective The objective analyze outcome thoracoscopic mesh repair hepatic hydrothorax ( HH ) institution investigator past 10 year . Methods A total 63 patient refractory HH , underwent thoracoscopic mesh onlay reinforcement repair diaphragmatic defect January 2005 December 2014 , include study . Mesh cover alone use 47 patient mesh suture used 16 patient . Patient demographic , Child-Pugh class , model end-stage liver disease ( MELD ) score evaluate predict morbidity mortality .</detailed_description>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Hydrothorax</mesh_term>
	<criteria>patient refractory hepatic hydrothorax ( &gt; 3 time thoracentesis failure maximal dos diuretic ) Patients systemic bacteremia , positive culture bacteria pleural effusion ascites exclude study potential mesh contamination .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>hepatic hydrothorax</keyword>
	<keyword>thoracoscopic surgery</keyword>
	<keyword>diaphragmatic defect</keyword>
</DOC>